9 research records

Tissue & Regenerative Biology

Explore peptides studied in cellular responses, mitochondrial biology and tissue models, including Elamipretide, LL-37 and Thymosin Beta-4. Each record explains the level and scope of the evidence.

Research materials only. Not for human or animal consumption.

Authorised product

Elamipretide

A mitochondria targeting tetrapeptide with accelerated FDA approval for a defined Barth syndrome strength endpoint; broader mitochondrial myopathy and heart failure programmes remain investigational or have not met key endpoints.

View record and quotation
Blend not evaluated

KLOW Blend 80mg

An 80mg lyophilised four peptide blend for tissue repair and inflammation research. The combination has not been evaluated in published studies.

View record and quotation
Preclinical

TB-500 10mg

A 10mg lyophilised synthetic peptide corresponding to a region of thymosin beta 4. Studied in cell and animal models, with no human trials for this peptide.

View record and quotation
Preclinical

BPC-157

Research is dominated by animal and laboratory soft tissue, gastrointestinal, tendon, ligament, and muscle injury models.

Read research record
Early human

LL-37

An investigational human cathelicidin studied in topical venous leg ulcer trials and exploratory biomarker work; its broad antimicrobial, immune, regenerative and oncology research remains largely preclinical.

Read research record
Preclinical

Thymosin β4 (1–4)

A short thymosin beta 4 fragment listed in tissue biology research. Evidence for full length thymosin beta 4 should be distinguished from evidence for this four residue fragment.

Read research record